close

Cardica, Inc. designs, manufactures, and markets proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass surgery. The company's products include C-Port Distal Anastomosis System, which is designed to perform an end-to-side distal anastomosis by attaching the end of a bypass graft to a coronary artery downstream of an occlusion or narrowing; C-Port Flex A Anastomosis System that includes modifications to the C-Port xA system designed to enable automated anastomoses to be performed as part of minimally invasive and robot-facilitated CABG procedures; and C-Port X-CHANGE system, a cartridge-based reloadable C-Port system. Its products also comprise PAS-Port Proximal Anastomosis System, an automated device used to perform an end-to-side proximal anastomosis between a saphenous vein and the aorta. In addition, the company develops the Cook Vascular Closure Device to be used in interventional vascular procedures. Cardica primarily sells the C-Port systems in the United States and Europe, and the PAS-Port systems in Europe and Japan through distributors. Cardica, Inc., formerly known as Vascular Innovations, Inc., was founded in 1997 and is headquartered in Redwood City, California.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	2.05
Volume	173491
Volume Avg	82508
52 Week High	4.11
52 Week Low	1.47
PE	N/A
PE (group average)	39
EPS Year	-0.48
EPS change Q/Q	-7.69%
EPS change Q/Q Yr ago	-16.67%
EPS change Q/Q next Q est	-40%
EPS change Y/Y	-300%
REV change Q/Q	-16.67%
REV change Q/Q Yr ago	0%
EPS next Q est	-0.10
EPS next Y est	-0.41
Divident Annual	0.00
Dividend Yield	0%